Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3675505 | 1.00 | ACHE (0.43) | ACHEKMT2AEPHX1CA1CA2 | |
| Cyclohexane SCHEMBL3670822 | 1.00 | ACHE (0.43) | ACHEKMT2AEPHX1CA1CA2 | |
| SCHEMBL802 | 1.00 | — | — | |
| SCHEMBL5189 | 1.00 | — | — | |
| SCHEMBL9256078 | 1.00 | ACHE (0.43) | ACHEKMT2AEPHX1CA1CA2 | |
| Cycloheptane SCHEMBL23885013 | 1.00 | ACHE (0.43) | ACHEKMT2AEPHX1CA1CA2 | |
| SCHEMBL7912061 | 1.00 | ACHE (0.43) | ACHEKMT2AEPHX1CA1CA2 | |
| SCHEMBL15121491 | 1.00 | ACHE (0.43) | ACHEKMT2AEPHX1CA1CA2 | |
| SCHEMBL9791506 | 1.00 | ACHE (0.43) | ACHEKMT2AEPHX1CA1CA2 | |
| SCHEMBL866985 | 1.00 | ACHE (0.43) | ACHEKMT2AEPHX1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020204188-A1 | PRODUCTION METHOD FOR CYCLIC OLEFIN COPOLYMER | ポリプラスチックス株式会社 | 2020-10-08 | — | — | WO | disclosed |
| CN-107112366-B | Organic thin film transistor | 日本曹达株式会社 | 2020-07-10 | — | — | CN | disclosed |
| US-20200179914-A1 | METHOD FOR PRODUCING CATALYST | POLYPLASTICS CO., LTD. (JP) | 2020-06-11 | — | — | US | disclosed |
| WO-2020071494-A1 | METHOD FOR PRODUCING CYCLIC OLEFIN POLYMER | ポリプラスチックス株式会社 | 2020-04-09 | — | — | WO | disclosed |
| EP-2617746-B1 | NOVEL COPOLYMER | NIPPON SODA CO (JP) | 2018-01-10 | — | — | EP | disclosed |
| WO-2017079718-A1 | METHODS OF FORMING AROMATIC CONTAINING COMPOUNDS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2017-05-11 | — | — | WO | disclosed |
| US-20150166528-A1 | Pesticidal methods using substituted 3-pyridyl thiazole compounds and derivatives for combating animal pests | BASF SE (DE) | 2015-06-18 | — | — | US | disclosed |
| US-9018311-B2 | Copolymer | NIPPON SODA CO., LTD. (JP) | 2015-04-28 | — | — | US | disclosed |
| US-8791142-B2 | Oxazole pyridine derivatives useful as S1P1 receptor agonists | MERCK SERONO S.A. (CH) | 2014-07-29 | — | — | US | disclosed |
| US-20130217832-A1 | NOVEL COPOLYMER | NIPPON SODA CO., LTD. (JP) | 2013-08-22 | — | — | US | disclosed |
| EP-2617746-A1 | NOVEL COPOLYMER | Nippon Soda Co., Ltd. (JP) | 2013-07-24 | — | — | EP | disclosed |
| US-20110306636-A1 | OXAZOLE PYRIDINE DERIVATIVES USEFUL AS S1P1 RECEPTOR AGONISTS | MERCK SERONO SA (CH) | 2011-12-15 | — | — | US | disclosed |
| CN-101534904-A | BCL inhibitors for the treatment of platelet excess | ABBOTT LAB (US) | 2009-09-16 | — | — | CN | disclosed |
| US-7449542-B2 | Polymers | XEROX CORPORATION (US) | 2008-11-11 | — | — | US | disclosed |
| US-20070093641-A1 | POLYMERS | XEROX CORPORATION | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166528-A1 | Pesticidal methods using substituted 3-pyridyl thiazole compounds and derivatives for combating animal pests | PTMS, PDXK, TH | ACHE 10/4885KMT2A 2849/4885EPHX1 1683/4885 |
| US-20110306636-A1 | OXAZOLE PYRIDINE DERIVATIVES USEFUL AS S1P1 RECEPTOR AGONISTS | S1PR1, S1PR3, S1PR5 | ACHE 3451/4885KMT2A 3880/4885EPHX1 779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.